EFFECTS OF 23 DRUGS ON THE METABOLISM OF FK506 BY HUMAN LIVER-MICROSOMES

Citation
K. Iwasaki et al., EFFECTS OF 23 DRUGS ON THE METABOLISM OF FK506 BY HUMAN LIVER-MICROSOMES, Research communications in chemical pathology and pharmacology, 82(2), 1993, pp. 209-216
Citations number
12
Categorie Soggetti
Pharmacology & Pharmacy",Pathology
ISSN journal
00345164
Volume
82
Issue
2
Year of publication
1993
Pages
209 - 216
Database
ISI
SICI code
0034-5164(1993)82:2<209:EO2DOT>2.0.ZU;2-M
Abstract
We investigated the effects of 23 drugs on the metabolism of FK506 by human liver microsomes. Acyclovir, amphotericin B, cefixime, cefotaxim e, ciprofloxacin, cyclosporin A, diltiazem, enoxacin, erythromycin, et hinyl estradiol, fluconazole, fosfomycin, kanamycin, lincomycin, loxop rofen, minocyclin, nifedipine, nilvadipine, norethindrone, ofloxacin, phenobarbital, prednisolone, or rifampicin was added to the reaction m edia at equimolar or at ten times an excess molar ratio of the substra te concentration; their effects on FK506 metabolism were examined. Dru gs known to be the substrate of cytochrome P-450 3A inhibited the meta bolism of FK506, and among the drugs tested, the inhibition by cyclosp orin A and nifedipine was the strongest.